Wion Web Desk

The Royals enter the Doctor Who universe: King Charles and Queen Camilla beam into Commonwealth Games in TARDIS

'I was almost trafficked in Paris,' says Australian woman, shares terrifying ordeal - 'I am on the black market'

Why did India turn down the US offer for F-35 fighter jets? EXPLAINED

India avoids higher US tariff, secures lower 10% rate. Here's how

DMK leader Udhayanidhi Stalin detained over 'double-meaning' Trisha remark in Vijay's Tamil Nadu

22 children dead, 35 infected: India's Gujarat faces Chandipura virus outbreak — Experts explain symptoms

Meet top 5 bowlers in latest ICC ODI rankings 2026 - check who sits at the top

Can an S-400 detect a bird?

'Fifth-generation fighters': Can the S-400 shoot down an F-35?

Trump, Putin kissing in Amsterdam? Pride parade’s ‘couple’ goes viral | WATCH

Pakistan minister admits ‘system has collapsed’, Munir pushes for more provinces | Gravitas

Why are iPhones so expensive compared to Android phones?

Bombay High Court canteens inspected after judges question Maharashtra FDA's 'selective' crackdown

WI vs PAK, 2nd Test: Shafique and skipper Babar lead fightback with unbroken 168-run stand on Day 2

Trump says Iranian school bombing photos could be AI-generated - 'I don’t think...'

Pakistan 'blocks' Al Jazeera website over PoJK reportage: So it's not about 'kafirs', is it?

Influencer killed on livestream: Mexican cartel boss' son asked dad to kill woman who broke up with him

What’s happening in Nepal? How did a local clash turn into communal violence? WION Decodes

7 longest flights in the world - Singapore, Qantas, Qatar and others

Multiple WhatsApp accounts, including in India, are under review for 24 hours. Here’s why

PM Modi expected to visit Kyrgyzstan and Uzbekistan as India firms up Central Asia ties

Who is Devendra Nath Mahto, Jharkhand’s 'Sonam Wangchuk' fasting for protesting students?

Meet top 5 bowlers in latest ICC Test rankings 2026 - check who sits at the top

Meet top 5 batters in latest ICC Test rankings 2026 - check who sits at the top

Meet top 5 bowlers in latest ICC T20I rankings 2026 - check who sits at the top

'He is courageous leader': DK Shivakumar after TN CM Vijay postpone his Cauvery-related Karnataka visit

Why Russian tanks are much lighter compared to US tanks

Tamil Nadu leader Udhayanidhi Stalin draws severe backlash over derogatory remark against Trisha

Why Russian jets use heavier steel compared to US jets

New OTT releases this week (August 3-9, 2026): Main Vaapas Aaunga, Uyir, Operation Safed Sagar- 6 titles coming on Netflix, Prime Video and more

Wipro's margins fall to 15-quarter low as AI investment eats into profit

Why Russian fighter pilots wear blue flight suits compared to US pilots

How often does an S-400 need maintenance?

Zydus Healthcare, a subsidiary of Cadila Healthcare, today said it has acquired two Abbreviated New Drug Applications&nbsp;(ANDAs) from Teva Pharmaceutical in the US for an undisclosed sum. 
 
An ANDA contains data which when submitted to FDA&#39;s Center for Drug Evaluation and Research, Office of Generic Drugs, provides for the review and ultimate approval of a generic drug product. 
 
&quot;Zydus has strengthened its US portfolio with the acquisition of two ANDAs from Teva that are being divested by Teva as a pre-condition to its acquisition of Allergan&#39;s generic business,&quot; Cadila Healthcare said in a Bombay Stock Exchange (BSE) filing. 
 
It further said: &quot;The acquisition of these ANDAs is contingent on the closing of the Teva-Allergan Genercis transaction and approval by the US Federal Trade Commission. Financial details of the transaction are undisclosed.&quot; 
 
The company said these ANDAs have been acquired by its 100 per cent subsidiary, Zydus Worldwide DMCC, and will be financed through the group&#39;s internal accruals. 
 
Giving details about the ANDAs, the company said: &quot;The acquired portfolio comprises an ANDA which is already commercialised and one pipeline ANDA which is a transdermal patch. The estimated market size of the two ANDAs put together is nearly US$ 200 million.&quot; 
Shares of Cadila Healthcare were trading 1.09 per cent higher at Rs 316.75 on BSE. 
(PTI) 
&nbsp;

ANDAs

 Zydus Healthcare

 Cadila

 TEVA

 pharma

 India pharma news

 Business & Economy News

 wionews.com

Zydus Healthcare, a subsidiary of Cadila Healthcare, today said it has acquired two Abbreviated New Drug Applications (ANDAs) from Teva Pharmaceutical in the US for an undisclosed sum. An ANDA contains data which when submitted to FDA's Center for Drug Evaluation and Research, Office of Generic Drugs, provides for the review and ultimate approval of a generic drug product. "Zydus has strengthened its US portfolio with the acquisition of two ANDAs from Teva that are being divested by Teva as a pre-condition to its acquisition of Allergan's generic business," Cadila Healthcare said in a Bombay Stock Exchange (BSE) filing. It further said: "The acquisition of these ANDAs is contingent on the closing of the Teva-Allergan Genercis transaction and approval by the US Federal Trade Commission. Financial details of the transaction are undisclosed." The company said these ANDAs have been acquired by its 100 per cent subsidiary, Zydus Worldwide DMCC, and will be financed through the group's internal accruals. Giving details about the ANDAs, the company said: "The acquired portfolio comprises an ANDA which is already commercialised and one pipeline ANDA which is a transdermal patch. The estimated market size of the two ANDAs put together is nearly US$ 200 million." Shares of Cadila Healthcare were trading 1.09 per cent higher at Rs 316.75 on BSE. (PTI)

Zydus Healthcare estimates that the market size of the two ANDAs put together is nearly US$ 200 million

Pills tumble down the belt at a drug manufacturing plant. (Representative image)

Indian pharma company buys 2 ANDAs from US drug maker

Pills tumble down the belt at a drug manufacturing plant. (Representative image)

Zydus Healthcare estimates that the market size of the two ANDAs put together is nearly US$ 200 million

About the Author

Wion Web Desk

Wion Web Desk

Trending Topics